Questionnaire

1. The EMA recently withdrew from its markets those cough medications that contain:

2. An increased anaphylactic risk upon anaesthetic intervention requiring the use of a NMBA is still evident in the patient who used pholcodine:

3. Dextromethorphan:

4. Peak cough flow can be used to assess respiratory muscle function and airway clearance.

5. Acute cough is usually caused by:

6. Probable causes of excessive coughing arising from URTIs and other disease conditions are:

7. Cough can only be stimulated via the reflex brainstem cough centre.

8. Panthenol:

9. Referral to a pulmonologist is necessary for the patient whose cough, despite initial treatment by the general practitioner, persists for:

10. For the management of acute general cough bouts, the current most effective approach is to use: